Journal of Bacteriology, June 1999, p. 3505-3515, Vol. 181, No. 11
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

andDepartment of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520-8103
Received 21 December 1998/Accepted 30 March 1999
| |
ABSTRACT |
|---|
|
|
|---|
VanK is the fourth member of the ubiquitous major facilitator
superfamily of transport proteins to be identified that, together with
PcaK, BenK, and MucK, contributes to aromatic catabolism in
Acinetobacter sp. strain ADP1. VanK and PcaK have
overlapping specificity for p-hydroxybenzoate and, most
clearly, for protocatechuate: inactivation of both proteins severely
impairs growth with protocatechuate, and the activity of either protein
alone can mask the phenotype associated with inactivation of its
homolog. Furthermore, vanK pcaK double-knockout mutants
appear completely unable to grow in liquid culture with the
hydroaromatic compound quinate, although such cells on plates convert
quinate to protocatechuate, which then accumulates extracellularly and
is readily visible as purple staining. This provides genetic evidence
that quinate is converted to protocatechuate in the periplasm and is in
line with the early argument that quinate catabolism should be
physically separated from aromatic amino acid biosynthesis in the
cytoplasm so as to avoid potential competition for intermediates common
to both pathways. Previous studies of aromatic catabolism in
Acinetobacter have taken advantage of the ability to select
directly strains that contain a spontaneous mutation blocking the
-ketoadipate pathway and preventing the toxic accumulation of
carboxymuconate. By using this procedure, strains with a mutation in
structural or regulatory genes blocking degradation of vanillate,
p-hydroxybenzoate, or protocatechuate were selected. In
this study, the overlapping specificity of the VanK and PcaK permeases
was exploited to directly select strains with a mutation in either
vanK or pcaK. Spontaneous mutations identified
in vanK include a hot spot for frameshift mutation due to
contraction of a G6 mononucleotide repeat as well as point
mutations producing amino acid substitutions useful for analysis of
VanK structure and function. Preliminary second-site suppression
analysis using transformation-facilitated PCR mutagenesis in one VanK
mutant gave results similar to those using LacY, the prototypic member
of the major facilitator superfamily, consistent with the two proteins
having a similar mechanism of action. The selection for transport
mutants described here for Acinetobacter may also be
applicable to Pseudomonas putida, where the PcaK permease has an additional role in chemotaxis.
| |
INTRODUCTION |
|---|
|
|
|---|
One of the defining characteristics
of a microorganism is the spectrum of compounds that are transported
across the cell membrane, and it is therefore of interest to examine
the diversity of proteins that have evolved to contribute to an
organism's transport capacity (7). Genome sequencing has
revealed that a significant fraction of transport proteins
(64) can be grouped either into the ATP-binding cassette
(ABC) superfamily or the major facilitator superfamily. In the soil
bacterium Acinetobacter sp. strain ADP1, permeases associated with the
-ketoadipate pathway for catabolism of aromatic compounds appear exclusively to be members of the major facilitator superfamily (61): BenK (9) and MucK
(77) are involved in uptake of compounds in the benzoate
branch of the pathway, and PcaK (8, 45) is involved in the
p-hydroxybenzoate branch. This study concerns VanK, a fourth
member of the superfamily associated with aromatic catabolism in
Acinetobacter.
Studies of the
-ketoadipate pathway in Acinetobacter have
taken advantage of the ability to use a strain with the engineered
pcaBDK1 deletion to directly select derivatives in which
a spontaneous mutation prevents the toxic accumulation of
carboxymuconate (Fig. 1). By using this
procedure, strains that contained a structural gene mutation
inactivating the VanAB vanillate demethylase (69), the PobA
p-hydroxybenzoate hydroxylase (13, 33), or the
PcaHG protocatechuate dioxygenase (12, 28) were selected.
Also selected were strains with a regulatory gene mutation inactivating
either of two transcriptional activators (14, 26): PobR
(14, 27, 43, 44), governing expression of PobA, or PcaU
(11), governing expression of PcaH and PcaG (31).
As described in this study, the gene for the PcaK transport protein is
already inactivated by the
pcaBDK1 deletion in the
parental strain ADP500, which consequently allowed the selection of
derivatives with a mutation in VanK, a protein closely related to and
overlapping in specificity with PcaK.
|
The genetic analysis presented here was made possible by characterization of a chromosomal segment containing vanA and vanB, structural genes for vanillate demethylase (69). As shown in Fig. 2, these genes, essential for growth with vanillate, neighbor an open reading frame designated vanK on the basis of its genetic location and its sequence similarity to other transporters associated with aromatic catabolism (69). The other investigation (69) did not associate a phenotype with vanK. That knowledge emerged from the present study, initiated by discovery that in strains defective in pcaK, mutations in vanK protect cells against toxicity exerted by protocatechuate. The vanK mutations occur with remarkable frequency, and so double mutants unable to express both protocatechuate oxygenase and VanK are likely to emerge from exposure of cells to protocatechuate in a single round of mutant selection (Fig. 1). The genetic bases for the genetic instability of vanK are reported here and elsewhere (69). Mutations blocking both pcaK and vanK impede growth with either protocatechuate or quinate (Fig. 1) and cause extracellular accumulation of protocatechuate from the latter compound. vanK is the first observed chromosomal locus that can specifically influence protocatechuate catabolism and is not within the pca-qui-pob supraoperonic cluster (17, 30, 35).
|
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and culture conditions. Acinetobacter sp. strain ADP1, originally called Acinetobacter calcoaceticus BD413 (39), was routinely grown with 10 mM succinate in a mineral medium. Unless otherwise indicated, cells were grown at 37°C and the mineral medium was supplemented with 5 mM p-hydroxybenzoate, 3 mM quinate, 3 mM vanillate, 3 mM protocatechuate, or 2.5 mM benzoate. Because of the instability of protocatechuate, only fresh plates or liquid cultures with this carbon source were used, made with stock solutions (pH 7.0) stored frozen until use. For characterization of mutant phenotypes, strains were tested after overnight growth on plates with 10 mM succinate.
DNA manipulations. Crude cell lysates of Acinetobacter strains for use in transformation reactions were prepared by incubation of pelleted cells (from a 5-ml culture) in 0.5 ml of saline-citrate buffer with 0.05% sodium dodecyl sulfate at 60°C for 1 h. Plasmids were isolated from 5-ml Escherichia coli cultures by using the Wizard miniprep kit (Promega) and assumed to contain 2 µg of DNA. To isolate template DNA for PCR, pelleted Acinetobacter cells from a 5-ml culture were washed and treated with InstaGene Matrix as described by the supplier (Bio-Rad); 5 µl of the resulting solution was then used in 50-µl PCRs including 0.5 U of Taq polymerase (Boehringer Mannheim), 10 pmol of each primer, and 10 pmol of each deoxynucleoside triphosphate. Standard PCR conditions were used: 30 cycles of denaturing at 94°C for 45 s, annealing at 56°C for 45 s, and elongation at 72°C for 1 min 30 s. PCR primers were synthesized by the Keck Biotechnology Resource Laboratory (Yale University).
For efficient transformation of Acinetobacter strains, 200 µl of a 5-ml culture of the recipient strain grown overnight with 10 mM succinate was transferred to a fresh 5-ml culture. After growth in a gyratory shaker for 2 h (to increase competence), 500 µl of the culture was transferred to Falcon 15-ml polypropylene tubes together with 1 µg of plasmid DNA or 20 µl of a 50-µl PCR mixture. After overnight shaking incubation, transformation reactions were transferred to appropriate selective plates.Selection and characterization of strains deficient in
vanK.
Strain ADP500 (32) contains the engineered
catD101::Kmr and
pcaBDK1 mutations. To isolate mutants blocked in
catabolism of protocatechuate, single colonies of succinate-grown
ADP500 were transferred to patches on freshly prepared plates with 10 mM succinate and 3 mM protocatechuate. Cells with spontaneous secondary
mutations blocking protocatechuate catabolism do not accumulate toxic
levels of
-carboxy cis,cis-muconate and are able to grow (Fig. 1). To prevent analysis of siblings, only one mutant
derivative was picked per single colony of ADP500.
pcaBDK1 deletion in 16 such strains generated ADP1102 to ADP1117, each with a spontaneous
heat-sensitive mutation in either pcaH or -G (12). To identify and to map potential spontaneous mutations in vanK in addition to the conditional mutation in
pcaH or -G, the
pcaBDK1 deletion in
the 16 strains was replaced on the chromosome with
pcaK859 (8) instead of wild-type DNA by the
following procedures. Recipient strains were patched onto an LB plate
together with 1 µl of crude cell lysate of ADP859
(
pcaK859). After overnight growth, cells from each patch
were transferred to and purified on plates with 5 mM
p-hydroxybenzoate incubated at 37°C, thereby demanding
correction of the heat-sensitive mutation in pcaH or -G as well as activity of PcaBD. This generated strains
ADP7576 to ADP7591 (Table 1; equivalent
to strains ADP1102 to ADP1117 with the addition of
pcaK859), which were then tested for growth with quinate.
Strains severely impaired in growth with quinate (or protocatechuate)
due to inactivation of both vanK and pcaK were
patched onto an LB plate together with about 50 ng of plasmid pZR139,
pZR143, or pZR144 (69) (Fig. 2). After overnight growth, cells from each patch were transferred to a plate with 3 mM quinate: wild-type growth with quinate indicated marker rescue and allowed rough
localization of the spontaneous vanK mutation.
|
pcaBDK1 deletion) with a cold-enhanced
resistance to p-hydroxybenzoate were found to have a
spontaneous mutation affecting transcriptional regulation by PcaU and
are described elsewhere. Strains that resisted protocatechuate but not
p-hydroxybenzoate at both 37 and 22°C were purified on an
LB plate and then tested for the ability to grow on a plate with 10 mM
succinate in the presence of 3 mM vanillate (which does not require a
functional vanK for its metabolism). Strains from this
selection (still containing the
pcaBDK1 deletion) with a
cold-enhanced resistance to p-hydroxybenzoate were found to
have a spontaneous mutation affecting transcriptional regulation by
PcaU and were described elsewhere (11). Strains not
resistant to p-hydroxybenzoate at either 37 or 22°C were
purified on an LB plate and then tested for the ability to grow on a
plate with 10 mM succinate in the presence of 3 mM vanillate. For those
strains also not resistant to vanillate and therefore assumed to have a
spontaneous mutation confined to vanK, crude cell lysates
were made. To identify complementation groups, these lysates were
tested for the ability to transform strains carrying
pcaK859 combined with various sequenced mutations in
vanK to wild-type growth with quinate: 5-ml cultures of the
double-mutant recipient strains were grown overnight with 10 mM
succinate and, after addition of 10 µl of 1 M succinate, incubated
for an additional 30 min in a gyratory shaker (to increase competence)
before being spread onto selective plates with 3 mM quinate. Lysate (4 µl) of each mutant was spotted onto the cell lawn. Because the
pcaBDK1 deletion in the donor strains overlapped the
pcaK859 mutation in the recipients, wild-type growth with
quinate was possible only when the lysate DNA corrected the
vanK mutation; no growth was readily observed when the donor
and recipient contained the same or overlapping mutations in
vanK. Strains which appeared to have a unique
vanK mutation were treated as described above:
pcaBDK1 was replaced on the chromosome with
pcaK859, generating ADP7602 to ADP7609 (Table 1), and the
vanK mutation was mapped by marker rescue.
To reconstruct and to analyze the selection pressure for
vanK inactivation, the
pcaBDK1 and
pcaBD1 deletions each were introduced into the chromosome
of an ADP500 derivative carrying only the spontaneous
vanK1103 mutation, generating ADP7592 and ADP7593, respectively (Table 1). To construct such strains, liquid cultures were
transformed (as described above) with one of two plasmids: pZR301
(32), in which removal of two internal EcoRV
fragments from the pZR3 (28, 32) insert generated
pcaBDK1; and pZR35, in which removal of one of the
internal EcoRV fragments generated
pcaBD1.
Transformation reactions were streaked onto plates with 10 mM
succinate, and single colonies were tested for loss of the ability to
grow with p-hydroxybenzoate, indicating chromosomal replacement of wild-type pca genes with the engineered
deletion. Generally at least 1 in 500 colonies tested had the desired phenotype.
Transformation-facilitated PCR mutagenesis. For mutagenesis (12, 43, 44), standard PCR was performed as described above except that the number of cycles was increased to 35. For suppression of vanK1113, a 1.2-kb PCR fragment was amplified from ADP7587 by using primers VK3 (5'-GTTTAGCTATTGCAGGCATCAGC-3') and VK6 (5'-GCAATAAATTCGGCATGGACTAC-3'). For mutagenesis of pcaK, a 1.7-kb fragment was amplified from ADP7593 by using primers PK1 (5'-CATTGATTATCGCGGGTAGTGC-3') and PK2 (5'-CTCAAGTGAACGGTTAACATGC-3'). Twenty microliters of each PCR mixture was directly used to transform a liquid culture of the recipient strain (as described above).
DNA sequence analysis. To isolate template DNA for sequencing, products of PCRs performed under standard conditions were purified with 8 µl of GeneClean Glassmilk according to the supplier (Bio 101, Inc.) and resuspended in 25 µl of water; 8 µl was used for ABI PRISM dye terminator cycle sequencing with AmpliTaq DNA polymerase, FS (Perkin-Elmer). Cycle sequence reactions were processed as previously described (43). PCR primers were synthesized by the Keck Biotechnology Resource Laboratory (Yale University), which also performed some of the DNA sequencing. The nucleotide sequence of a 14-kb EcoRI fragment containing Acinetobacter wild-type vanK has been reported previously (69) and appears in the GenBank nucleotide sequence database under accession no. AF009672.
| |
RESULTS |
|---|
|
|
|---|
Additional mutations blocking conversion of vanillate to
protocatechuate in strains selected directly for a block in
protocatechuate utilization.
Selection for resistance to the
toxic accumulation of carboxymuconate in the engineered
Acinetobacter mutant ADP500 yields strains with secondary
mutations blocking the
-ketoadipate pathway upstream of PcaB (Fig.
1). By using this procedure, a collection of strains each with a
spontaneous mutation in pcaH or pcaG, structural genes for protocatechuate 3,4-dioxygenase (12, 28, 31), was
generated. One such mutant, ADP6311, contained a 302-bp deletion in
pcaG (28). As part of a study of catabolic
pathways in Acinetobacter potentially convergent upon
protocatechuate, it was shown that unlike the wild-type strain ADP1,
ADP6311 and other mutants blocked in pcaH and -G
could not grow with vanillate as sole carbon and energy source. This
was expected since the first step in vanillate catabolism is its
conversion to protocatechuate by vanillate demethylase (69)
(Fig. 1). However, when the supernatant of an ADP6311 culture grown in
the presence of vanillate was analyzed by high-pressure liquid
chromatography (data not shown), no accumulation of protocatechuate was
detected, indicating that contrary to expectation, the vanillate remained unmetabolized by this strain. Furthermore, ADP6338
(28), a spontaneous mutant containing a leaky four amino
acid deletion in PcaH causing slow growth with protocatechuate, was
unable to grow with vanillate.
Identification of vanK.
The apparent presence of a
deletion mutation preventing vanillate degradation in ADP6338 raised
the possibility that a selected mutation blocked vanK (which
proved not to be required for vanillate degradation) and that the
deletion mutation extended into vanA and vanB
(which are required for vanillate degradation [69] [Fig. 2]). Therefore, other ADP500-derived strains with no apparent block in vanillate degradation may also harbor an undetected mutation, and ADP1103 (12) was used to test this possibility. By
demanding growth with p-hydroxybenzoate at 37°C, a strain
in which the heat-sensitive pcaH1103 mutation had
spontaneously reverted was selected, and a subsequent test showed that
growth with vanillate was not detectably impaired. To reveal any
mutations other than pcaH1103 that might have been
originally selected in this strain, the
pcaBDK1 mutation was reintroduced into the chromosome (see Materials and Methods), generating ADP7592 (Table 1). Reconstructing the selection for resistance to carboxymuconate accumulation, it was found that ADP7592,
unlike the parental strain ADP500, appeared completely resistant to 1 mM protocatechuate but the 3 mM concentration used in the original
selection remained toxic.
Nucleotide sequence of vanK.
The vanK gene
(Fig. 3) encodes a protein of 448 amino
acids (Mr = 47,927) whose sequence indicates
that it is a member of the major facilitator superfamily of transport
proteins (52, 61). In a phylogenetic analysis (Fig.
4), VanK clusters with six other
proteins: PcaK (45) and BenK (9) in
Acinetobacter strain ADP1, PcaK (34, 56) in
Pseudomonas putida, MhpT (20) in E. coli, TfdK (48) in Ralstonia eutropha, and
HppK (2) in Rhodococcus globerulus. These six
permeases, known or predicted to mediate the uptake of aromatic acids,
form a new protein family within the superfamily (2, 61).
VanK is most closely related (37% identity over 442 amino acid aligned
residues [1]) to HppK, predicted to transport
3-hydroxyphenylpropionate, also the predicted substrate of MhpT. As
with LacY, the prototypic member of the major facilitator superfamily,
VanK and the other members of the aromatic acid permease family are
predicted to contain 12 membrane-spanning
-helical segments (Fig.
3), topologically oriented so that a large cytoplasmic loop is formed
by residues in the middle of the linear amino acid sequence. An amino
acid signature sequence for this family (61), including most
of the residues in transmembrane segment 2, is matched in 11 of 13 positions in the VanK sequence (Fig. 3, VanK residues 62 to 81). This
signature sequence in turn just overlaps with amino acids between
transmembrane segments 2 and 3 that had been previously identified as
characteristic of the superfamily (51, 61).
|
|
Spontaneous mutations inactivating vanK can be masked
by PcaK activity.
The
pcaBDK1 mutation in ADP500,
besides blocking the
-ketoadipate pathway at the level of
carboxymuconate, also inactivates pcaK. This loss of
pcaK function, however, does not protect ADP500 from the
toxic accumulation of carboxymuconate during growth in the presence of
even micromolar quantities of protocatechuate. Furthermore, growth on
plates with protocatechuate is not dramatically impeded in ADP859
(8), in which the
pcaK859-engineered 4-bp deletion (of one of the tandem TTAA repeats between nucleotides [nt]
4945 and 4952 [45]) inactivates the encoded permease
in an otherwise wild-type genetic background. This apparent redundancy of pcaK function suggested that spontaneous mutations in
vanK might contribute to protocatechuate resistance in
ADP500 but then go undetected after PcaK activity was restored by
correction of pcaBDK to wild type.
pcaK859 mutation was introduced into
the chromosome, inactivating pcaK (see Materials and
Methods). Tests of the resulting strains, ADP7576 to ADP7591 (Table 1),
revealed that 14 of 16, including the four strains with apparent
deletions overlapping vanK, were now severely impaired in
growth with protocatechuate or quinate. Excluding the four deletion
mutants, the spontaneous mutation in the remaining 10 strains was
localized to vanK by marker rescue with cloned DNA in
plasmids pZR139, pZR143, and pZR144 (69) (Fig. 2).
Subsequently, DNA sequencing of the appropriate region, in 8 of the 10 strains, revealed
vanK1103 (Fig. 3), a single-base
deletion in a string of six G residues (nt 366 to 371). The remaining
two strains had different mutations (Fig. 3):
vanK1108, a
single-base deletion in a string of seven A residues (nt 697 to 704) or
vanK1113, a point mutation causing substitution of
Gly71 with Asp71 in the VanK protein. These
results confirm the prediction that vanK can be a target of
spontaneous mutation during selection with strain ADP500 and that these
mutations can be masked by the activity of PcaK.
Role of vanK during selection of ADP500 derivatives
resistant to protocatechuate.
The reconstruction experiment with
ADP7592 showed that the
vanK1103 spontaneous mutation
alone could not provide resistance to protocatechuate at the
concentration (3 mM) used in the original selection. This explains the
necessity for the pcaH1103 mutation in addition to
vanK1103 in the original ADP500 derivative but does not
explain the order in which these two mutations arose. To determine when
vanK mutations may have arisen, the selection for mutant
derivatives of ADP500 was repeated. Mutant colonies growing in the
presence of 3 mM protocatechuate were purified by two successive
transfers on selective plates as in the original selections (12,
28). Mutant cells generally grew poorly during these transfers,
and frequently there appeared a mix of colony sizes. In a particularly
clear case after the second round of transfer, a crude cell lysate was
made from one relatively large colony. In contrast to lysates of other
samples of this mutant strain from the first and second transfers, the
DNA in the lysate of the large colony could not transform ADP7576
(Table 1), a strain deleted in vanK and containing the
pcaK859 mutation, to wild-type growth with
protocatechuate. This negative transformation result indicates that the
large colony had acquired an additional mutation preventing correction
of the ADP7576 vanK defect and implies that a mutation
inactivating vanK can arise by unintended selection during
purification on selective media of a mutant strain already impaired in
protocatechuate degradation.
Direct selection and characterization of strains with a spontaneous
mutation inactivating vanK.
The resistance of ADP7592
(
vanK1103
pcaBDK1) to growth at 37°C in the presence
of 1 mM or less protocatechuate suggested that these conditions could
be used to directly select ADP500 derivatives with spontaneous
mutations only in vanK. Indeed, such strains had almost
certainly already been isolated: it had been previously noted
(65) that by using these conditions to select ADP500
derivatives with spontaneous mutations in pcaH or
pcaG, strains with no change in phenotype apparent after
replacement of the
pcaBDK1 deletion on the chromosome
with wild-type DNA were also isolated, consistent with the presence of
a vanK mutation. Also consistent with the use of 1 mM
protocatechuate expanding the potential mutational targets compared to
selection with 3 mM protocatechuate, the former conditions consistently
yielded significantly more spontaneous mutant derivatives per ADP500 CFU.
vanK1103 mutation in ADP7582; because these strains
probably also carried
vanK1103, they were not analyzed further.
Each of the eight remaining strains, lysates of which could correct the
vanK mutation in all three recipients, appeared to have a
new mutation in vanK. As before, the
pcaBDK1
deletion in these mutants was replaced on the chromosome with
pcaK859, generating ADP7602 to ADP7609 (Table 1), and the
vanK mutation was localized by marker rescue with plasmids
pZR139, pZR143, and pZR144. DNA sequencing of the relevant
vanK regions revealed three cases of point mutations
producing amino acid substitutions in VanK: Gly154Trp in
VanK7604, Gln219Stop in VanK7608, and Arg378Pro in VanK7609 (Fig. 3). One strain had a 150-bp deletion
(
vanK7607) flanked by the 4-bp sequence ATTA, but the
deletion left both repeats present (Fig. 3). Three strains had
vanK7602 in which 96 bp is deleted, including one
flanking 8-bp repeat of the sequence GCTGGCGT (Fig. 3).
Intriguingly, a sequence identical in seven of eight positions is
involved in a spontaneous deletion mutation, mucK51
(77), in an Acinetobacter gene encoding a
permease closely related to VanK (Fig. 4), and the 3' endpoint of the
deletion is in the equivalent position of both genes.
PCR amplification of DNA containing the remaining mutation,
vanK7603, indicated an insertion of 1.2 kb, and sequencing
confirmed the presence of the Acinetobacter insertion
sequence IS1236 (27). Insertion of
IS1236 in the direction of vanK transcription
generated a 3-bp target site duplication (Fig. 3). This insertion
behavior, characteristic of the IS3 family (24),
was also seen in previous studies in the two regulator genes
pobR (27) and pcaU (11), in
contrast to three of four insertions in the pcaH structural gene (28). Tn5613, a newly discovered compound
transposon with identical copies of IS1236 at either end,
contributes to spontaneous mutation in Acinetobacter vanA
and vanB and also generates a 3-bp target site duplication
(69).
Overlapping specificities of VanK and PcaK revealed during
catabolism of protocatechuate, p-hydroxybenzoate, and
quinate.
To systematically identify compounds in the
-ketoadipate pathway (Fig. 1) for which VanK and PcaK had
overlapping specificities, ADP7592 (
vanK1103
pcaBDK1)
was tested for growth with 10 mM succinate at two temperatures (37 and
22°C) in the presence of various concentrations (0.1 to 5 mM) of
protocatechuate, p-hydroxybenzoate, quinate, or vanillate.
ADP500 (
pcaBDK1) was sensitive to these compounds under
all conditions and concentrations tested, indicating that
pcaK inactivation alone was not sufficient to provide
resistance. At 37°C, besides being resistant to 1 mM protocatechuate,
ADP7592 grew in the presence of 5 mM quinate or 0.1 mM
p-hydroxybenzoate. Higher concentrations of
p-hydroxybenzoate of vanillate at even 0.1 mM were toxic,
consistent with the phenotype observed during isolation of other
mutants, including those later shown to have larger deletions within
vanK (Fig. 3). Emphasizing the importance of growth
temperature, ADP7592 was resistant to 3 mM protocatechuate during
growth at 22°C but not 37°C. To test if inactivation of vanK alone was sufficient for any resistance, strain ADP7593
(
vanK1103
pcaBD1) was constructed (see Materials and
Methods). Growth tests with ADP7593 showed that no protection against
toxicity was provided only by vanK inactivation; therefore,
the observed resistance phenotypes required inactivation of both
vanK and pcaK.
pcaK859 mutation in combination with
vanK7602 or any of the other sequenced vanK
mutations (Fig. 3), growth on plates with 5 mM quinate or 3 mM
protocatechuate as sole carbon and energy source was barely detectable
after overnight incubation. Inactivation of both vanK and
pcaK was required for this phenotype: transformation of the
double-mutant strains with cloned DNA containing either vanK
or pcaK yielded recombinants able to grow with quinate or
protocatechuate at a level disguising the remaining mutation. In
contrast, overnight growth with p-hydroxybenzoate or
vanillate, either on plates or in liquid culture, was not clearly impaired for strains in which both vanK and pcaK
were dysfunctional. This finding is consistent with the observation
that inactivation of the two permease genes in ADP7592 did not prevent
the toxic accumulation of carboxymuconate during growth in the presence of vanillate and conferred resistance to p-hydroxybenzoate
only when supplied at a low concentration (0.1 mM). Furthermore, these same phenotypes were also observed in an engineered strain (ADP7614) in
which
pcaK859 was combined with an insertion into the
SphI site in vanK (69) of the
chloramphenicol resistance gene from pCAT19 (22).
VanK PcaK double mutants exhibited an even stronger phenotype with
protocatechuate and quinate in liquid culture. Strain ADP7602 (
vanK7602
pcaK859) was tested since phenotypic
revertants were readily obtained from other strains, especially those
with
vanK1103 (Fig. 3). Indeed, the first attempt to
sequence this latter mutation in ADP7585 and ADP7589 (Table 1) gave
results consistent with a mixed population of cells, including those in
which
vanK1103 had directly reverted. CFU from a 5-ml
culture inoculated with approximately 107 stationary-phase
cells of succinate-grown ADP7602 and provided either with 3 mM
protocatechuate or 3 mM quinate consistently had decreased 10- or
100-fold, respectively, after 24 h of shaking incubation. Cultures
with protocatechuate incubated for an additional 24 h would
generally become turbid, consistent with another transport system in
the cell having been activated by mutation. In contrast, cultures with
quinate continued to decrease in CFU, and no growth was ever observed
even after prolonged incubation (14 days).
Extracellular accumulation of protocatechuate during growth in the presence of quinate of strains blocked in vanK and pcaK. That the substrate specificity of VanK and PcaK might overlap to include the structurally similar aromatic compounds protocatechuate and p-hydroxybenzoate was unsurprising, but the strong phenotype associated with growth with the hydroaromatic compound quinate was unexpected (Fig. 1). A clue that the phenotype with quinate was indirect came from the observation that strains without a functional vanK and pcaK, growing on succinate in the presence of quinate, stained the medium a dramatic purple color characteristic of protocatechuate accumulation. This extracellular accumulation could be readily explained if conversion of quinate to protocatechuate in Acinetobacter takes place in the periplasm, outside the inner cell membrane (Fig. 5). Such compartmentation may cause a further obstacle to growth of vanK pcaK double mutants with quinate since the final step in conversion of quinate to protocatechuate, catalyzed by QuiC (Fig. 1), is susceptible to feedback inhibition by protocatechuate in at least one member of the genus Acinetobacter (74).
|
qui1
pcaBDK1) on a
plate with 10 mM succinate and 5 mM quinate (Fig.
6). Deletion in ADP603 of qui
genes (17), required for conversion of quinate to
protocatechuate, prevents the toxic accumulation of carboxymuconate during growth of this strain in the presence of quinate (Fig. 1).
Protocatechuate itself, however, remains toxic to ADP603. Growth of
ADP603, when adjacent to cells of ADP7577 (
vanK1103
pcaK859), was drastically inhibited as expected if
protocatechuate was accumulating extracellularly during growth of
ADP7577 in the presence of quinate (Fig. 6). This effect was also
produced, although less intensely, by protocatechuate diffusing from
cells in which either vanK or pcaK was
dysfunctional (Fig. 6).
|
Positive selection of strains with a mutation in pcaK.
In strains without PcaB function (Fig. 1), resistance to the toxic
accumulation of carboxymuconate produced during growth in the presence
of protocatechuate requires inactivation of both vanK and
pcaK. This requirement was exploited to select strains derived from ADP500 (
pcaBDK1), each with a spontaneous
mutation in vanK (Table 1; Fig. 3). The success of this
selection in turn suggested that in the appropriate genetic background,
pcaK mutants could be isolated by positive selection as
well. Previously, PCR-generated mutations had been introduced into the
Acinetobacter chromosome by natural transformation
facilitating genetic analysis of the structural genes pcaH
and pcaG (12, 43) and the regulatory genes,
pobR and pcaU (43, 44). Applying this
technique to pcaK, transformation of ADP7593
(
vanK1103
pcaBD1) with PCR-amplified DNA containing
the pcaK gene was followed by selection for growth with
succinate at 22°C in the presence of 1 mM protocatechuate. Consistent
with the introduction of PCR-generated mutations into pcaK
on the chromosome, transformants of ADP7593 that were resistant to
protocatechuate appeared at a frequency over 200-fold above the
spontaneous mutation frequency of approximately 1 in 106 CFU.
Intragenic suppression of a vanK point mutation.
The Gly71Asp substitution in VanK1113 (Fig. 3) changes an
amino acid residue conserved in all eight transport proteins in Fig. 4.
This conservation suggests that Gly71 is particularly important for VanK function. Therefore, to gain insight into how structure influences function in VanK, PCR mutagenesis was again used,
this time to obtain intragenic suppressors of vanK1113. PCR
amplification across vanK but excluding the
vanK1113 locus near the start of the gene produced DNA that
yielded recombinants of ADP7587 (vanK1113
pcaK859) that
could grow at 30°C like wild-type cells with quinate. DNA sequencing
of two such recombinants revealed in one of the strains, in addition to
vanK1113, two new mutations, vanK7610 and
vanK7611, causing Phe269Ser and
Phe271Ser substitutions, respectively (Fig. 3). In the
other recombinant, one new mutation, vanK7612, produced a
Gly294Arg substitution (Fig. 3).
| |
DISCUSSION |
|---|
|
|
|---|
Multiple spontaneous mutations in strains derived from a single
genetic selection.
The first evidence for the existence of
vanK came from the detection of two spontaneous mutations in
ADP500-derived strains selected for resistance to the toxic
accumulation of carboxymuconate produced during growth in the presence
of protocatechuate. One of these mutations was in pcaH or
pcaG, structural genes for protocatechuate 3,4-dioxygenase,
and the other inactivated vanK, encoding a putative transport system able to act on protocatechuate. A remarkably similar
result was described in two recent Acinetobacter studies involving a parallel branch of the
-ketoadipate pathway. Selection for resistance to the toxic internal accumulation of muconate also
generated strains with two spontaneous mutations, one in a structural
gene for benzoate or anthranilate degradation and one inactivating the
muconate transporter MucK (5, 77). The transporter mutation
in this case, although not sufficient to allow growth (77),
could have been beneficial by blocking the uptake of muconate
accumulating extracellularly at the onset of selection from the lawn of
cells of the parental strain (5, 23, 77). In the case of
vanK, multiple mutations may have been an artifact of the
selection procedure: in at least one ADP500 derivative already
resistant to protocatechuate, inactivation of vanK appeared
to confer additional resistance and was identified by its forming a
relatively large colony during purification on a plate with selective
media. The exact nature of the additional resistance provided by the
block in protocatechuate uptake is unclear but may reflect the relative
toxicity of this aromatic compound (62).
A hot spot for frameshift mutation in a poly(G) tract in
vanK.
In the 10 Acinetobacter strains analyzed by
DNA sequencing that had a spontaneous mutation in both vanK
and pcaH or pcaG, 8 contained
vanK1103, a single-nucleotide deletion in a string of 6 G
residues (Fig. 3). When strains in which only vanK had acquired a mutation were selected, a greater variety of mutations emerged, but still the majority (13 of 21) contained
vanK1103. The frequent selection of
vanK1103 identifies the mononucleotide repeat as a hot
spot for frameshift mutation. Furthermore, this poly(G) tract is not
conserved in the genes for the five permeases most closely related to
VanK, raising the possibility that the genetic instability reflected by
vanK1103 may be of adaptive significance to
Acinetobacter in the soil environment. High-frequency frameshifting in a poly(A) tract in a gene encoding an ABC transporter component (72) has been suggested to generate alternative
transport capabilities in mycoplasmas organisms with apparently limited transport systems (72), and phase variation due to
reversible frameshifting in a poly(G) tract has been described for
several bacterial genes involved in pathogenesis (6, 10,
38). The mutability of these contingency genes (55)
can facilitate adaptation to rapidly changing and unpredictable
environmental challenges (15, 55, 67), and this may apply to
Acinetobacter vanK as well.
Insight into VanK structure and function from second-site
suppressor mutations.
By demanding growth of ADP500
(
pcaBDK1) on succinate at 22°C in the presence of 3 mM
protocatechuate, strains with secondary spontaneous mutations in
vanK were isolated. Subsequent tests of lysates of these
spontaneous mutants in marker rescue experiments rapidly identified
strains with mutations not caused by the
vanK1103 frameshift hot spot. By using this simple procedure, a VanK missense mutation was found in three strains (Fig. 3): two mutations altered a
glycine, Gly71Asp (VanK1113) and Gly154Trp
(VanK7604), the former introducing a charged residue into a putative
membrane-spanning helix, and the third mutation was a substitution with
a proline residue, Arg378Pro (VanK7609). A combination of
selection with transformation-facilitated PCR mutagenesis (12, 43,
44), successfully tested on chromosomal pcaK in this
study, will allow the isolation of a large collection of strains with
point mutations useful for identifying amino acid residues critical for
structure and function of the two homologous Acinetobacter
transport proteins, VanK and PcaK.
|
Evidence that quinate is converted to protocatechuate in the periplasm. In Acinetobacter strain ADP1, the hydroaromatic compound quinate (Fig. 1) is converted to protocatechuate by the sequential action of three enzymes (QuiA, QuiB, and QuiC) encoded by genes in the pca-qui-pob supraoperonic cluster (17, 18, 30, 35). The reactions catalyzed by the catabolic enzymes QuiB and QuiC can interfere with the same reactions in the opposite physiological direction, performed by enzymes in the shikimate pathway for aromatic amino acid biosynthesis (18) (Fig. 5). In fungi, channeling of intermediates in an aggregate of the shikimate pathway biosynthetic enzymes prevents access by catabolic enzymes during growth with quinate (29, 46). Evidence for physical segregation of the two classes of enzymes has also been described in Acinetobacter (18, 74). Further evidence presented here supports catabolism of quinate to protocatechuate taking place in the periplasm: pcaK vanK double mutants severely impaired in growth with protocatechuate because of their inability to transport this compound across the inner membrane into the cytoplasm also are severely impaired in growth with quinate, although quinate appears to be efficiently converted to extracellular protocatechuate (Fig. 6). Periplasmic localization of QuiABC is consistent with the amino acid sequence of QuiA (17), which identifies it as a member of a family of membrane-associated, PQQ-dependent dehydrogenases (16), as well as a putative leader peptide in the N terminus of QuiB (18) which could mediate its export out of the cytoplasm.
Spontaneous mutant derivatives of ADP500 resistant to the toxic accumulation of carboxymuconate during growth in the presence of quinate never contained mutations confined to qui genes and were always blocked at the level of protocatechuate degradation (19). This observation can now be explained by the ease with which protocatechuate accumulates extracellularly after its generation in the periplasm from quinate. This is particularly true in strains blocked in PcaK such as ADP500 (Fig. 6) but is probably also relevant to the wild-type strain growing in the more natural condition of multiple carbon sources: significant amounts of protocatechuate accumulated when Acinetobacter was provided with shikimate, another substrate of QuiA (Fig. 5), simultaneously with three other carbon sources (23). This accumulation may reach local extracellular concentrations that are toxic to some competing soil microorganisms (Fig. 6). On the other hand, this "overflow metabolism" may mediate mutually beneficial cross-feeding (42). Similarly, bacterial growth on aromatic compounds can lead to extracellular accumulation of
-ketoadipate (23,
41), a chemoattractant that has been suggested to mediate the
formation of "catabolic consortia" (63) of soil
bacteria. In this light, reversible inactivation of Acinetobacter vanK by mutation at the frameshift hot spot may underlie a switch in membrane permeability important for cell-cell interactions.
Membership of Acinetobacter QuiA in a family of
PQQ-dependent membrane-bound dehydrogenases suggests a further link
between oxidation of quinate, a compound ubiquitous in the soil
environment (36), and active transport. The single step of
oxidation of glucose to gluconate by a dehydrogenase closely related to
QuiA has been shown in several organisms to generate a proton motive force which could efficiently power secondary transport systems (75). Conversion of quinate to dehydroquinate may likewise
power transport by PcaK and VanK, facilitating scavenging of aromatic compounds from the environment even in the absence of growth. Such a
role may explain why transcription of Acinetobacter quiA appears, at least in part, to be independently regulated
(18). Also, as has been suggested for gluconate production
from glucose in Pseudomonas (68), periplasmic
oxidation of quinate by Acinetobacter cells may serve to
rapidly remove this compound from access by competing soil microorganisms.
Overlapping specificity of the VanK and PcaK transport proteins. The pca operon encodes the PcaK transport protein together with all the enzymes for conversion of protocatechuate to citric acid cycle intermediates (45). The role of PcaK in protocatechuate transport can be masked by the overlapping specificity of VanK, encoded by a gene distant on the chromosome from the pca-qui-pob supraoperonic cluster and part of a separate cluster of genes for conversion of vanillate to protocatechuate (69) (Fig. 2). Despite the location of vanK, no evidence indicating that the encoded protein transports vanillate has yet been found, although the activities of yet to be identified transporters may well mask such a role. The full spectrum of compounds that can be transported by PcaK and VanK remains to be elucidated.
The results of this study, consistent with studies of P. putida PcaK (34, 56), indicate that both VanK and PcaK can mediate uptake of protocatechuate and p-hydroxybenzoate: inactivation of both proteins severely impairs growth with protocatechuate and, in cells lacking PcaB function, prevents toxic accumulation of carboxymuconate during growth in the presence of low levels of p-hydroxybenzoate. This latter phenotype should allow the genetic dissection of transport of these two compounds by Acinetobacter PcaK. After transformation-facilitated PCR mutagenesis of chromosomal pcaK in ADP7593 (
vanK1103
pcaBD1), recombinant cells selected for
resistance to protocatechuate can be screened for lack of resistance to
an appropriate concentration of p-hydroxybenzoate. This
procedure should identify strains with a PcaK amino acid substitution
in which only protocatechuate uptake is significantly impaired.
The requirement for either VanK or PcaK for efficient growth with
protocatechuate may support the idea that transport systems play a
fundamental role in regulating cytoplasmic levels of metabolites that
are also inducers of gene expression (58, 59). This concept has been recently emphasized (2) following studies of
aromatic catabolism which revealed linkage on the chromosome of a gene for a PcaK family member and a gene for a regulatory protein predicted to respond to the aromatic substrate of the transporter. In this light,
the apparent redundancy of VanK and PcaK is consistent with the need to
concentrate the same inducer-metabolite in two spatially segregated
cellular compartments. The most likely candidate for this inducer is
protocatechuate, given that it activates pca operon
expression (26, 44) and, although it awaits determination in
Acinetobacter, it also appears to induce expression of
vanA and vanB in Pseudomonas
(76).
Facilitating the channeling of protocatechuate after it enters the
cytoplasm, the gene clusters containing vanK and
pcaK may become associated with the cytoplasmic membrane by
coupling of transcription of these genes with translation and membrane
insertion of the encoded proteins (49, 50). The substrate
specificity of the transport protein encoded in each gene cluster would
thereby become pivotal: capable of either preventing cross talk between biochemical pathways or conversely, of efficiently mediating such interactions (66). A more general role in the
-ketoadipate pathway of metabolic channeling by enzyme complexes
(21, 53, 60, 71) has been suggested to underly the
supraoperonic clustering (23) of genes in
Acinetobacter as well as an explanation of the different
effects caused by an inducer added extracellularly versus made
endogenously as described for both Acinetobacter
(23) and Pseudomonas (54).
A previous study of Acinetobacter examined the genetic
flexibility of two closely related transcriptional activators
associated with protocatechuate catabolism and found that no more than
two amino acid substitutions were required for each protein to
functionally replace its homolog (44). Similarly, only one
amino acid substitution was required for protocatechuate dioxygenase to
functionally replace catechol dioxygenase (12). This study
outlines a genetic system for studying the contribution to
protocatechuate catabolism of two homologous transport proteins, VanK
and PcaK, already overlapping in specificity. Recognition of this
overlap is particularly important given that the activity of the LacY
permease can generate nongenetic heterogeneity of lac operon
expression in E. coli cells exposed to suboptimal levels of
inducer (57, 73). While this phenomenon provides yet another
source of variability for bacteria to deal with environmental change
(73), it is likely to complicate laboratory measurements of
transport activity, gene expression, and growth rates in
Acinetobacter if the activities of both VanK and PcaK are
not taken into account. Genetic analysis of these two permeases in
Acinetobacter also may complement characterization of
P. putida PcaK, which has an additional role in chemotaxis
(34, 56). Such a comparative approach may reveal new
properties of aromatic acid transport systems, such as a spatial
organization in the membrane (4, 70), and should be
particularly useful in elucidating the molecular biology of
self-identity (35).
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by grants DAAG55-98-1-0232 from the Army Research Office and MCB-9603980 from the National Science Foundation. A.S. was supported by a postdoctoral fellowship from the Spanish Ministerio de Educación y Ciencia.
The overlapping specificity of VanK and PcaK was recognized thanks to the faithful recording of anomalous phenotypes of ADP500 derivatives by D. Elsemore, D. Eulberg, T. Plaggemeier, and P. West. Discussion with E. P. Greenberg prompted consideration of possible additional roles played by the membrane-associated QuiA dehydrogenase. The plate photograph was taken by W. Sacco.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular, Cellular and Developmental Biology, Yale University, P.O. Box 208103, New Haven, CT 06520-8103. Phone: (203) 432-3498. Fax: (203) 432-3497. E-mail: nicholas.ornston{at}yale.edu.
Publication 20 from the Biological Transformation Center in the
Yale Biospherics Institute.
Present address: Department of Biochemistry, Consejo Superior de
Investigaciones Científicas, Estación Experimental de
Zaidín, 18012 Granada, Spain.
§ Present address: Energy Biosystems, The Woodlands, Tex.
Present address: Institut für Allgemeine Botanik, Abteilung
Mikrobiologie, Hamburg, Germany.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altschul, S. F.,
T. L. Madden,
A. A. Schäfer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 2. |
Barnes, M. R.,
W. A. Duetz, and P. A. Williams.
1997.
A 3-(3-hydroxyphenyl)propionic acid catabolic pathway in Rhodococcus globerulus PWD1: cloning and characterization of the hpp operon.
J. Bacteriol.
179:6145-6153 |
| 3. | Benson, S. A., A. M. DeCloux, and J. Munro. 1991. Mutant bias in nonlethal selections results from selective recovery of mutants. Genetics 129:647-658[Abstract]. |
| 4. | Bray, D., M. D. Levin, and C. J. Morton-Firth. 1998. Receptor clustering as a cellular mechanism to control sensitivity. Nature 393:85-88[Medline]. |
| 5. |
Bundy, B. M.,
A. L. Campbell, and E. L. Neidle.
1998.
Similarities between the antABC-encoded anthranilate dioxygenase and the benABC-encoded benzoate dioxygenase of Acinetobacter sp. strain ADP1.
J. Bacteriol.
180:4466-4474 |
| 6. | Carroll, P. A., K. T. Tashima, M. B. Rogers, V. J. DiRita, and S. B. Calderwood. 1997. Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae. Mol. Microbiol. 25:1099-1111[Medline]. |
| 7. | Clayton, R. A., O. White, K. A. Ketchum, and J. C. Venter. 1997. The first genome from the third domain of life. Nature 387:459-462[Medline]. |
| 8. | Coco, W. M., and L. N. Ornston. 1997. Acinetobacter PcaK is a multispecificity active facilitator of aromatic acid transport, abstr. K-81, p. 355. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C. |
| 9. |
Collier, L. S.,
N. N. Nichols, and E. L. Neidle.
1997.
benK encodes a hydrophobic permease-like protein involved in benzoate degradation by Acinetobacter sp. strain ADP1.
J. Bacteriol.
179:5943-5946 |
| 10. |
Danaher, R. J.,
J. C. Levin,
D. Arking,
C. L. Burch,
R. Sandlin, and D. C. Stein.
1995.
Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation.
J. Bacteriol.
177:7275-7279 |
| 11. | D'Argenio, D. A., A. Segura, P. V. Bünz, and L. N. Ornston. Unpublished data. |
| 12. | D'Argenio, D. A., M. W. Vetting, D. H. Ohlendorf, and L. N. Ornston. Unpublished data. |
| 13. | DiMarco, A. A., B. A. Averhoff, E. E. Kim, and L. N. Ornston. 1993. Evolutionary divergence of pobA, the structural gene for p-hydroxybenzoate hydroxylase in an Acinetobacter calcoaceticus strain well-suited for genetic analysis. Gene 125:25-33[Medline]. |
| 14. |
DiMarco, A. A.,
B. Averhoff, and L. N. Ornston.
1993.
Identification of the transcriptional activator pobR and characterization of its role in the expression of pobA, the structural gene for p-hydroxybenzoate hydroxylase in Acinetobacter calcoaceticus.
J. Bacteriol.
175:4499-4506 |
| 15. | DiRita, V. J., and J. J. Mekalanos. 1989. Genetic regulation of bacterial virulence. Annu. Rev. Genet. 23:455-482[Medline]. |
| 16. | Duine, J. A. 1991. Quinoproteins: enzymes containing the quinoid cofactor pyrroloquinoline quinone, topaquinone or tryptophan-tryptophan quinone. Eur. J. Biochem. 200:271-284[Medline]. |
| 17. |
Elsemore, D. A., and L. N. Ornston.
1994.
The pca-pob supraoperonic cluster of Acinetobacter calcoaceticus contains quiA, the structural gene for quinate-shikimate dehydrogenase.
J. Bacteriol.
176:7659-7666 |
| 18. | Elsemore, D. A., and L. N. Ornston. 1995. Unusual ancestry of dehydrata |